These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34345035)

  • 21. Organizational effectiveness: a key to R&D productivity.
    Tollman P; Panier V; Dosik D; Biondi P; Cuss F
    Nat Rev Drug Discov; 2016 Jul; 15(7):441-2. PubMed ID: 27312725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 23. Driving operational excellence across research.
    Cunningham MR
    Drug Discov Today; 2011 Jul; 16(13-14):541-2. PubMed ID: 21558017
    [No Abstract]   [Full Text] [Related]  

  • 24. Can emerging drug classes improve R&D productivity?
    Meier C; Cairns-Smith S; Schulze U
    Drug Discov Today; 2013 Jul; 18(13-14):607-9. PubMed ID: 23702084
    [No Abstract]   [Full Text] [Related]  

  • 25. Open PHACTS: semantic interoperability for drug discovery.
    Williams AJ; Harland L; Groth P; Pettifer S; Chichester C; Willighagen EL; Evelo CT; Blomberg N; Ecker G; Goble C; Mons B
    Drug Discov Today; 2012 Nov; 17(21-22):1188-98. PubMed ID: 22683805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemical Biology Consortium Sweden.
    Hammarström LG; Jensen AJ
    ACS Chem Biol; 2013 Dec; 8(12):2605-6. PubMed ID: 24354290
    [No Abstract]   [Full Text] [Related]  

  • 28. Opening the lead generation toolbox.
    Simpson PB; Reichman M
    Nat Rev Drug Discov; 2014 Jan; 13(1):3-4. PubMed ID: 24378783
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 30. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 31. Q&A: Bernard Munos.
    Bender E
    Nature; 2016 May; 533(7602):S59. PubMed ID: 27167392
    [No Abstract]   [Full Text] [Related]  

  • 32. Gene-testing firms set sights on drug development.
    Check Hayden E
    Nature; 2015 Apr; 520(7549):597-8. PubMed ID: 25925454
    [No Abstract]   [Full Text] [Related]  

  • 33. A blueprint for an ideal corporate information centre.
    Renn O; Archer M; Burkhardt C; Ginestet J; Nielsen HP; Woodward J;
    Nat Rev Drug Discov; 2012 May; 11(6):497. PubMed ID: 22596254
    [No Abstract]   [Full Text] [Related]  

  • 34. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 35. Made in Africa.
    Nordling L
    Nat Med; 2013 Jul; 19(7):803-6. PubMed ID: 23836210
    [No Abstract]   [Full Text] [Related]  

  • 36. AI could threaten pharmaceutical patents.
    Heuer L
    Nature; 2018 Jun; 558(7711):519. PubMed ID: 29950627
    [No Abstract]   [Full Text] [Related]  

  • 37. The ethics of drug development and promotion: the need for a wider view.
    Brody H
    Med Care; 2012 Nov; 50(11):910-2. PubMed ID: 23047778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. News & Analysis: new initiative aims to improve success of early stage drug discovery.
    Coaker H
    Future Med Chem; 2014 May; 6(7):733. PubMed ID: 24941869
    [No Abstract]   [Full Text] [Related]  

  • 39. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 40. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
    Takebe T; Imai R; Ono S
    Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.